Key facts
- This page summarizes Athanasios Skarpelos's Form 4 filing for ANAVEX LIFE SCIENCES CORP. (AVXL).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 23 Feb 2024, 06:03.
Athanasios Skarpelos - 20 Feb 2024 Form 4 Insider Report for ANAVEX LIFE SCIENCES CORP. (AVXL)
- Role
- Director
- Signature
- /s/Athanasios Skarpelos
- Issuer symbol
- AVXL
- Transactions as of
- 20 Feb 2024
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 23 Feb 2024, 06:03:06 UTC
- Previous filing
- 04 Apr 2023
- Next filing
- 02 Apr 2025
- SEC
- View on sec.gov
Key filing fact
Athanasios Skarpelos filed Form 4 for ANAVEX LIFE SCIENCES CORP. (AVXL) on 23 Feb 2024.
Change
- Previous filing in this sequence was filed on 04 Apr 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
AVXL
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +50,000
- Change %
- Price
- $0.000000
- Shares after
- 50,000
- Date
- 20 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $5.36
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Athanasios Skarpelos is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Options vest in equal installments over three years from the grant date. |